{"name":"Vigil Neuroscience, Inc.","slug":"vigil-neuroscience-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxPMTFSeXY3dkhHMlk4bFd2TmIxLUNpY2lqNDM3LXowSmlnT2V3akp1ejd0Y19IeWI5QUNIZ1liUXNKZjdNT01IUDZYU0V2YjVtd3h3WmI3NEJpQWNuXzBfUkxpOS03RGo3eUx6cGNTdW9XbS1mNW1SWWdUcTJvSy1ia0Z4ZWZ5MGhtcnJLMjByb19CUEN6UmFrOXFB?oc=5","date":"2026-01-14","type":"pipeline","source":"pharmaphorum","summary":"Changing Faces: Pharma and biotech hires, November and December 2025 - pharmaphorum","headline":"Changing Faces: Pharma and biotech hires, November and December 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE80QlBQMjFRMVIzdGpIdWNLMXR6R3JKX0I4UlBBZTZxNXN3eUV2clhBaDZybXVNbDUyY1VJQmxwcUFiUGRyNmdDRC1jNDY4MVhmdWRIcnFDZGdfQXR5eEdj?oc=5","date":"2025-09-01","type":"deal","source":"Nature","summary":"Neurodegeneration deals maintain neuroscience momentum - Nature","headline":"Neurodegeneration deals maintain neuroscience momentum","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxQeTJMcWNMalFKYnQzamdhdnJvcFducWR1MzdjNEhoeDRZWEswOWRKVDVHamJ3cDhzRU1CUTVwMFdZaWdObUFWSWMzQVZ5dTJqd1Mzend5VlF4ZllMX1RnM2VMcXBCejNYVHRNOXlHbk0zUmZKTTF3WjNvdkIxZUZFS0JVUmk1N0xCZE1ORWFLZEZWX0doU2VEenlxdXctOVJZQjhzY1pVSkw4d9IBrwFBVV95cUxQWVdpaEh2MXk3RGk1RndhaFI2RWlpR21UZ3U1NW0yaW1md0dCdkpiYndxQTgwQ3JVVTFBM1F1bkhhQzBsYTJfd1FsRUV0cE14bFhuc2lNRFROaFNHalZieGNYSXB6ckY5QXVYZm9yTTAtdmVlOEptSmpOdzJabXZQWXVDRGxGc2d4MHBZcUhIeDgybzJLSWkxSHNjS3BMLXlXb2RuRzNHQUdEVjFQTzhn?oc=5","date":"2025-08-06","type":"pipeline","source":"medicaldialogues.in","summary":"Sanofi completes acquisition of Vigil Neuroscience - medicaldialogues.in","headline":"Sanofi completes acquisition of Vigil Neuroscience","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxQeTBMY3NxLWJoaXMxdFlfX1lORkVOR05Qa3JaUkd4MkQwYzJfRE14OFd0S3lMSFBRZDdSMlVrekxQeER4dFB6d2Z0QWk4QWNxZE9JZTFmaVZZMlc2TVd3UHJJT193bVM1c1hQUmdOcU9zemFRejRwQ3N4T3FZd3pJTWJvd0xiU2hzdEltazJ3?oc=5","date":"2025-06-30","type":"pipeline","source":"capitalanalyticsassociates.com","summary":"As M&A slows, Boston’s biotech sector stands out - capitalanalyticsassociates.com","headline":"As M&A slows, Boston’s biotech sector stands out","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxQN2wzNFdHTDNla2x0M19VRTh3U3BPdzBjZGZIcU1XeWxlbnBMRzd4Q1N3U2dzcmNjS0tJMlFOa1N1YkxEWElaZWw4aFNLS2Y3MTY1LWdmUVdSaXdKdmc4cDY3WHNJSzFiSzNHbUx3SkpxUWtyVWYtMDQyUDJqSHVlYjcxb1VrcmVVc3FPXzRrZDc3Rmt0Wkp6cmFsSkwwMGl5U3UzS1k3d1hwZnBU?oc=5","date":"2025-06-27","type":"pipeline","source":"statnews.com","summary":"Proposed cuts could have ‘catastrophic effect,’ 110 biomedical, health sciences industry leaders tell Congress - statnews.com","headline":"Proposed cuts could have ‘catastrophic effect,’ 110 biomedical, health sciences industry leaders tell Congress","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTFBxb19zNUdWX2VmaERmcTBYNFg5VG5uanhLVExGWTBIVURGRkZJQ2J5U0lOc0YzTFdTTlFhcVk5RzY1S25ZYVY1MDBBVzhsYjcxQ3Jz?oc=5","date":"2025-06-04","type":"trial","source":"FirstWord Pharma","summary":"Sanofi-bound Vigil says iluzanebart flops in rare neuro disease study - FirstWord Pharma","headline":"Sanofi-bound Vigil says iluzanebart flops in rare neuro disease study","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxNREg1NVVia1dDbGFxLVgyZzJLMVNodTVScmVFSFVDb09hS05Ca0pqRUtqNWJJX3pYZldhdWdCSVAzLVM2Yk04UDBQeEQxbUQ2NFF4ZEdvS2ZwQmN0eWYzRllXMWZEaHh1ZFlQaXEwR1BkN1V4ejNmZVJLUVBVSHJOelJOU2ZxSzVPb0xVNlFjWXhrTS1p?oc=5","date":"2025-05-23","type":"pipeline","source":"The Business Journals","summary":"Sanofi to spend $470M for Watertown biotech’s Alzheimer’s drug - The Business Journals","headline":"Sanofi to spend $470M for Watertown biotech’s Alzheimer’s drug","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxOSndHVzFTNEZ0aFBQel8xY0pQdTRhbnUzbVU4X1F1TGdzNk1YUmpLRVlldzN0SmttdVY5aG1nZVpqSlRHOXMxczV0cWZ5QUVRcTFLdXhMUEpNampqM1YxRnk4bUlDY09UVE50MW9hdE41MnRYaUphWHJqSHo1WURuaGZWX280OFJPcWJZY1NCNmVkanRRVlE?oc=5","date":"2025-05-22","type":"deal","source":"Contract Pharma","summary":"Sanofi Acquires Vigil Neuroscience for $470M - Contract Pharma","headline":"Sanofi Acquires Vigil Neuroscience for $470M","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxQdG5XeEUzUzZld1p4eU12aTBKTjl5NXdlQ09xdW5GaFJzZDVsV196R2NSLVBacUozT1FBV2J1SlVsNU1DQ2l3ZEItbnNJSzdkdXlBaVBpMURXZGQyWk82d0FfNl8tUHBoclpId0dzYmtfZGJlT1htUWVGNmIzM1JiUENLc09IV1JWamZTd0ZISnpjQmNjTFVnSFNHNmJhVk5ZZGVZWndJZlNlSmdVcTdLTW9rNG1zdw?oc=5","date":"2025-05-22","type":"pipeline","source":"Investopedia","summary":"Vigil Neuroscience Stock Triples as Drugmaker Agrees to Acquisition by Sanofi - Investopedia","headline":"Vigil Neuroscience Stock Triples as Drugmaker Agrees to Acquisition by Sanofi","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxNTVlGOFVxTC16Y29EOWt5V0l4ZWxxak03NnZnaVNObWF4NDRUYmoyYllzcUk0aENjLTNETEZVdGptVkU5RjFVNzF6MzZKeE9tMjAyUHh6cmgydzdEeDZ2TWlTdEpIdW8tZGE0UHJKWDR0Y3pRcjB1RWNoblJsXzVRMjRueXBiSWdZcmNwdmFhSjFISEFzNDc5M293?oc=5","date":"2025-05-22","type":"deal","source":"BioPharma Dive","summary":"Sanofi gains experimental Alzheimer’s drug through Vigil buyout - BioPharma Dive","headline":"Sanofi gains experimental Alzheimer’s drug through Vigil buyout","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxOSmxpOVFoZFpHMmhLaEZYU1pEWVFZUXdnLVdoUm1JQkp2NXM2dUFNZXp3RG0tVDk2ZGRiMzhGM3l3eE1haXZFcGl2Y1RoeFZHQ3I3a1dHY3VhU1BKcEVtVFgzbW9GWXZQZDBWQkR0UlpIQV9TS1l6VGFMTHJhZ004ZUpZTXNqSDExanJ3TVY3UUZyZ0JOQzM1OFlZNVltcW5JODJGWExGZFE?oc=5","date":"2025-05-22","type":"deal","source":"BioSpace","summary":"Sanofi Buys Vigil for $470M Upfront, Reigniting a Battered Alzheimer’s Target - BioSpace","headline":"Sanofi Buys Vigil for $470M Upfront, Reigniting a Battered Alzheimer’s Target","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxQaHZRRlpMdkZLUWdvUGRkQWFJTWNqTTNaVTZrRFN2WnF6QUtoVUZ6T3QzWExYbzdKVUR0djZzbjVlNEpROEFVZmNkTTlrTXdrNkJTQ1k5RnRSbllZMDRLN3k2UXN6UFBxV2dqRW8tV2F6ckRobHJXSnpsek54MklEckxyZl9jRU40bFpLVlI0eHJXTWZ1VXdYMGZNUTRHUQ?oc=5","date":"2025-05-21","type":"deal","source":"WSJ","summary":"Sanofi to Buy Vigil Neuroscience for About $470 Million - WSJ","headline":"Sanofi to Buy Vigil Neuroscience for About $470 Million","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}